Form 8-K - Current report:
SEC Accession No. 0001493152-21-014657
Filing Date
2021-06-17
Accepted
2021-06-17 16:15:29
Documents
20
Period of Report
2021-06-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 60114
2 ex1-1.htm EX-1.1 239880
3 ex5-1.htm EX-5.1 12962
4 GRAPHIC ex5-1_01.jpg GRAPHIC 2854
5 ex99-1.htm EX-99.1 14456
6 logo_001.jpg GRAPHIC 4297
7 ex99-2.htm EX-99.2 15094
8 logo_002.jpg GRAPHIC 4676
  Complete submission text file 0001493152-21-014657.txt   644518

Data Files

Seq Description Document Type Size
9 XBRL SCHEMA FILE hrow-20210617.xsd EX-101.SCH 3746
10 XBRL DEFINITION FILE hrow-20210617_def.xml EX-101.DEF 27699
11 XBRL LABEL FILE hrow-20210617_lab.xml EX-101.LAB 37631
12 XBRL PRESENTATION FILE hrow-20210617_pre.xml EX-101.PRE 26317
13 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5376
Mailing Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215
Business Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215 615.733.4731
HARROW HEALTH, INC. (Filer) CIK: 0001360214 (see all company filings)

EIN.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35814 | Film No.: 211024921
SIC: 2834 Pharmaceutical Preparations